Publication: SEOM-GECOD clinical guideline for unknown primary cancer (2021).
Loading...
Identifiers
Date
2022-03-23
Authors
Losa, Ferran
Fernandez, Isaura
Etxaniz, Olatz
Gimenez, Alejandra
Gomila, Paula
Iglesias, Lara
Longo, Federico
Nogales, Esteban
Sanchez, Antonio
Soler, Gemma
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Springer
Metrics
Export
Abstract
Cancer of unknown primary site (CUP) is defined as a heterogeneous group of tumors that appear as metastases, and of which standard diagnostic work-up fails to identify the origin. It is considered a separate entity with a specific biology, and nowadays molecular characteristics and the determination of actionable mutations may be important in a significant group of patients. In this guide, we summarize the diagnostic, therapeutic, and possible new developments in molecular medicine that may help us in the management of this unique disease entity.
Description
MeSH Terms
Humans
Neoplasms, Unknown Primary
Molecular Medicine
Gain of Function Mutation
Patients
Neoplasms, Unknown Primary
Molecular Medicine
Gain of Function Mutation
Patients
DeCS Terms
Metástasis de la neoplasia
Neoplasias pulmonares
Inmunohistoquímica
Neoplasias cutáneas
Neoplasias pulmonares
Inmunohistoquímica
Neoplasias cutáneas
CIE Terms
Keywords
Cancer, Diagnosis, Treatment, Unknown primary site
Citation
Losa F, Fernández I, Etxaniz O, Giménez A, Gomila P, Iglesias L, et al. SEOM-GECOD clinical guideline for unknown primary cancer (2021). Clin Transl Oncol. 2022 Apr;24(4):681-692